Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Biological Efficacy of Twice Daily Aspirin in Type 2 Diabetic Patients With Coronary Artery Disease

NCT01617031 is registered in ClinicalTrials.gov with Hopital Lariboisière as lead sponsor.

NCT NCT01617031
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01617031 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Biological Efficacy of Twice Daily Aspirin in Type 2 Diabetic Patients With Coronary Artery Disease
Lead sponsor
Hopital Lariboisière
Phase
Observational
Overall status
Completed
Start date
September 30, 2010
Completion date
May 31, 2012
Enrollment
92 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes mellitus